116
Participants
Start Date
August 26, 2024
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2027
GR1803 injection
D1 given at a dose of 30ug/kg, D4 given at a dose of 90ug/kg, D8 given at a dose of 180ug/kg, followed by weekly dosing up to cycle 9, and cycle 10 and onwards, every 2 weeks, with a dosing cycle of every 4 weeks
RECRUITING
he First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
INDUSTRY